rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2004-4-14
|
pubmed:abstractText |
DNA binding ligands with potent antimicrobial activity against Gram-positive bacteria were further optimized by variation of the internal aromatic amino acids. This modification led to compounds with improved in vivo efficacy in lethal murine models of peritonitis (methicillin-resistant S. aureus, MRSA) and lung infection (S. pneumoniae).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0960-894X
|
pubmed:author |
pubmed-author:BürliRoland WRW,
pubmed-author:ChenAlfredA,
pubmed-author:DuanJian-XinJX,
pubmed-author:GeYigongY,
pubmed-author:GrossMatthewM,
pubmed-author:HuWenhaoW,
pubmed-author:IwamotoMariM,
pubmed-author:JiangVernonV,
pubmed-author:JohnsonKirk WKW,
pubmed-author:JonesPeterP,
pubmed-author:KaizermanJacob AJA,
pubmed-author:MoserHeinz EHE,
pubmed-author:StantonTimothyT,
pubmed-author:TouamiSofiaS,
pubmed-author:TruongKietK
|
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2067-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15080980-Amino Acids, Aromatic,
pubmed-meshheading:15080980-Animals,
pubmed-meshheading:15080980-Anti-Bacterial Agents,
pubmed-meshheading:15080980-DNA,
pubmed-meshheading:15080980-Disease Models, Animal,
pubmed-meshheading:15080980-Ligands,
pubmed-meshheading:15080980-Lung Diseases,
pubmed-meshheading:15080980-Mice,
pubmed-meshheading:15080980-Peritonitis,
pubmed-meshheading:15080980-Staphylococcal Infections,
pubmed-meshheading:15080980-Staphylococcus aureus,
pubmed-meshheading:15080980-Streptococcal Infections,
pubmed-meshheading:15080980-Streptococcus pneumoniae
|
pubmed:year |
2004
|
pubmed:articleTitle |
DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids.
|
pubmed:affiliation |
Genesoft Pharmaceuticals, 7300 Shoreline Court, South San Francisco, CA 94080, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|